343 related articles for article (PubMed ID: 7991713)
1. [Clomipramine and other serotonin reuptake inhibitors in the treatment of depressed mood, anxiety and impaired impulse control].
Eriksson E
Psychiatr Pol; 1994; 28(5):601-12. PubMed ID: 7991713
[TBL] [Abstract][Full Text] [Related]
2. Can recovery from depression be achieved?
Shelton RC; Tomarken AJ
Psychiatr Serv; 2001 Nov; 52(11):1469-78. PubMed ID: 11684742
[TBL] [Abstract][Full Text] [Related]
3. [Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?].
Möller HJ; Bauer M; Fritze J; Haen E; Laux G; Müller WE; Rüther E
MMW Fortschr Med; 2005 Jan; 147(3):43-5. PubMed ID: 15727113
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders.
Nutt DJ; Forshall S; Bell C; Rich A; Sandford J; Nash J; Argyropoulos S
Eur Neuropsychopharmacol; 1999 Jul; 9 Suppl 3():S81-6. PubMed ID: 10523062
[TBL] [Abstract][Full Text] [Related]
5. Use of clomipramine in the treatment of anxiety-related and obsessive-compulsive disorders in cats.
Seksel K; Lindeman MJ
Aust Vet J; 1998 May; 76(5):317-21. PubMed ID: 9631696
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic management of obsessive-compulsive disorder.
Jackson CW; Morton WA; Lydiard RB
South Med J; 1994 Mar; 87(3):310-21. PubMed ID: 8134850
[TBL] [Abstract][Full Text] [Related]
7. Care of depressed patients with anxiety symptoms.
Nutt DJ
J Clin Psychiatry; 1999; 60 Suppl 17():23-7; discussion 46-8. PubMed ID: 10446738
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors in mixed anxiety-depression.
Berk M
Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S41-5. PubMed ID: 11110018
[TBL] [Abstract][Full Text] [Related]
9. SSRIs and SNRIs: broad spectrum of efficacy beyond major depression.
Gorman JM; Kent JM
J Clin Psychiatry; 1999; 60 Suppl 4():33-8; discussion 39. PubMed ID: 10086481
[TBL] [Abstract][Full Text] [Related]
10. The functional anatomy, neurochemistry, and pharmacology of anxiety.
Ninan PT
J Clin Psychiatry; 1999; 60 Suppl 22():12-7. PubMed ID: 10634350
[TBL] [Abstract][Full Text] [Related]
11. [Proofs of efficacy].
Boyer P
Encephale; 1999 Jun; 25 Spec No 2():29-31; discussion 32-5. PubMed ID: 10434157
[TBL] [Abstract][Full Text] [Related]
12. Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety.
Blier P; Szabo ST
J Clin Psychiatry; 2005; 66 Suppl 8():30-40. PubMed ID: 16336034
[TBL] [Abstract][Full Text] [Related]
13. Spotlight on paroxetine in psychiatric disorders in adults.
Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
[TBL] [Abstract][Full Text] [Related]
14. A review of pharmacologic treatments for obsessive-compulsive disorder.
Kaplan A; Hollander E
Psychiatr Serv; 2003 Aug; 54(8):1111-8. PubMed ID: 12883138
[TBL] [Abstract][Full Text] [Related]
15. New developments in the neurobiological basis of anxiety disorders.
Gorman JM; Hirschfeld RM; Ninan PT
Psychopharmacol Bull; 2002; 36 Suppl 2():49-67. PubMed ID: 12490823
[TBL] [Abstract][Full Text] [Related]
16. [The use of antidepressants to treat depression in children and adolescents].
Desombre H; Paccalin C; Revol O; Fourneret P
Arch Pediatr; 2006 Jun; 13(6):711-3. PubMed ID: 16697608
[No Abstract] [Full Text] [Related]
17. Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine.
den Boer JA; Westenberg HG; De Leeuw AS; van Vliet IM
Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():47-52. PubMed ID: 7622824
[TBL] [Abstract][Full Text] [Related]
18. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
Humble M
Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic and noradrenergic reuptake inhibitors: prediction of clinical effects from in vitro potencies.
Frazer A
J Clin Psychiatry; 2001; 62 Suppl 12():16-23. PubMed ID: 11430614
[TBL] [Abstract][Full Text] [Related]
20. OCD: where the serotonin selectivity story begins.
Pigott TA
J Clin Psychiatry; 1996; 57 Suppl 6():11-20. PubMed ID: 8647793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
